AI, crypto, aerospace, and market momentum—decoded for everyday traders.
Editor’s Note
This edition breaks down key catalysts including Musk’s interplanetary ambitions, the rebound in uranium, and how AI infrastructure plays are shaping the next wave of IPOs. Each article includes critical insights and sponsor spotlights for deeper due diligence.
Elon Musk’s SpaceX Update Fuels Mars Mission Hopes
Musk preps Mars-focused Starship update
SpaceX’s anticipated Starship launch comes amid renewed interest in deep-space exploration. Elon Musk’s remarks signal renewed urgency to position the U.S. as the frontrunner in planetary travel. Analysts suggest the market is watching aerospace suppliers, satellite firms, and defense contractors closely. With space tech ETFs gaining traction, momentum traders may find tailwinds building as early as this quarter. There’s also a secondary effect—media buzz could spill into AI and robotics sectors as NASA and private space companies scale automation.
This company’s GPU stacking strategy could power AI’s trillion-dollar future. Get in before Wall Street notices.
RTX Contract Agreement Ends Worker Strike
Machinists at Pratt & Whitney approve revised deal
Workers at RTX’s Connecticut facilities have ratified a new contract after nearly a month of disruptions. The agreement ends a strike that threatened production timelines during a crucial period of defense procurement ramp-up. Investors had been wary of further delays given RTX’s strategic role in the U.S. defense supply chain. Aerospace stocks could see relief rallies, and long-term implications include stabilized earnings forecasts for both RTX and downstream subcontractors.
Used by Hasbro & Sweetgreen. Backed by Adobe & Fidelity. See why RAD’s pre-IPO buzz is real.
CDC Reverses Vaccine Guidance for Key Groups
COVID vaccine pulled from child, pregnancy schedules
The CDC’s decision to drop vaccine recommendations for pregnant women and children has sparked fresh debate over public health autonomy. Health Secretary RFK Jr. argues the shift prioritizes informed consent. The pharmaceutical sector may see ripple effects in valuation, particularly among vaccine-heavy players. Watch for volatility in biotech ETFs. Meanwhile, anti-pharma sentiment appears to be driving narrative momentum online, a signal for sentiment-driven traders to monitor.
Ethereum, Bitcoin, and… the next one? See full predictions now.
Circle Targets $6.7B Valuation in IPO Filing
Stablecoin firm makes Wall Street debut push
Circle Internet, the company behind the USDC stablecoin, has filed to go public targeting a $6.7 billion valuation. The move reflects broader optimism in digital assets following renewed institutional interest. Analysts note that a successful IPO could solidify stablecoins as mainstream financial instruments. Regulatory uncertainty remains a wild card, but Circle’s timing aligns with a broader risk-on shift in the crypto space.
Only $0.80/share. Rapid setup housing at scale. See investment circular.
Disclosure: This is a paid ad for Boxabl’s Reg A offering. See details at invest.boxabl.com. This is a message from Boxabl.
Disclaimer: This is a paid advertisement for educational purposes only and does not constitute financial advice. Investing involves risk and may not be suitable for all individuals. Past performance does not guarantee future results.
Trading Cheat Sheet is owned and operated by PROTRADING RESEARCH LLC. We are not licensed financial advisors. Always consult with a certified financial professional before making investment decisions.
IMPORTANT NOTICE AND DISCLAIMER
PROTRADING RESEARCH LLC (“PTR”), the owner of this website (the “Website”), cannot guarantee the accuracy or completeness of the information contained in any article, email, newsletter, or other publication posted on or viewed in connection with this website (the “Publications”). The author or authors of those Publications are solely responsible for their contents. PTR has not done any research or due diligence into the markets, industries, or companies which may appear or be mentioned in the Publications. PTR will NOT be liable for any loss or damage caused by a reader’s reliance on information posted on the Website or contained in the Publications.
FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY; NOT INVESTMENT ADVICE.
This Website and the Publications are for educational and informational purposes only. This Website and the Publications do not purport to be a complete analysis of any company’s financial position. This Website, the Publications or any statements made in the Publications are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. This Website or the statements made in the Publications should NOT be relied upon for purposes of transacting in any securities posted on the Website or mentioned in the Publications, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security posted on this Website or mentioned in any Publications.
SUBSTANTIAL RISK IN INVESTMENT.
Any individual who chooses to invest in any securities including those mentioned in the Publications should do so with caution. Investing or transacting in securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers bear responsibility for their own investment research and decisions and should review all investment decisions with a licensed or registered investment professional.
NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER
Neither PTR nor any of its respective owners or employees are registered or licensed as a securities broker-dealer, broker, an investment advisor, or an investment advisor representative with the U.S. Security Securities and Exchange Commission (SEC), any state securities regulatory authority, or any self-regulatory organization.
To view our full policies: Disclaimer | Privacy Policy | Terms & Conditions
{{companyName}}
{{physicalAddress}}